Home > European Drug Emergencies Network (Euro-DEN Plus): data and analysis.

European Union Drugs Agency. (2025) European Drug Emergencies Network (Euro-DEN Plus): data and analysis.

External website: https://www.euda.europa.eu/publications/data-facts...


On this EUDA page you can explore data from the hospitals participating in the European Drug Emergencies Network (Euro-DEN — Euro-DEN Plus) project. Since 2013, the project has been collecting data on acute drug toxicity presentations in an expanding network of sentinel hospitals across Europe and beyond. Euro-DEN Plus aims to provide detailed information on the nature and extent of acute harm associated with the use of illicit drugs, such as cannabis, cocaine, heroin and other opioids, amphetamines, and new psychoactive substances, used alone or in combination with other drugs, prescription medicines, over the counter medicines and alcohol.

Data from all centres can be explored, by year and selected substances, through our interactive data explorer. In addition, we present a detailed analysis of the 2024 data available from the centres in 19 countries in the European Union and Norway. You can find out more about the Euro-DEN Plus project and the network of participating hospitals: European Drug Emergencies Network (Euro-DEN — Euro-DEN Plus).

Item Type
Webpage
Publication Type
International, Report
Drug Type
Substances (not alcohol/tobacco)
Intervention Type
Harm reduction
Date
December 2025
Publisher
EUDA
Corporate Creators
European Union Drugs Agency
Place of Publication
Lisbon
EndNote
Subjects
B Substances > Cannabis / Marijuana
B Substances > Substances in general
B Substances > CNS stimulants > Amphetamines
B Substances > CNS stimulants > MDMA / Ecstasy
B Substances > Cocaine
B Substances > Opioids (opiates) > Heroin (diacetylmorphine / diamorphine)
B Substances > Opioids (opiates) > Opioid product > Methadone
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Aminoindanes / Arylalkylamines / Arylcyclohexylamines > Ketamine
B Substances > New (novel) psychoactive substances > Benzodiazepines
B Substances > New (novel) psychoactive substances > Other novel substances > GHB / GBL (Gamma hydroxybutyric / Gamma butyrolactone)
F Concepts in psychology > Behaviour > Risk-taking behaviour (delay discounting)
G Health and disease > Substance use disorder (addiction) > Multiple / concurrent substance use (Poly-drug)
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug intoxication
J Health care, prevention, harm reduction and treatment > Risk and protective factors > Risk factors
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use
J Health care, prevention, harm reduction and treatment > Type of care > Emergency care
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Hospital
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
VA Geographic area > Europe
VA Geographic area > Europe > Ireland

Repository Staff Only: item control page